anti-inflammatory agents

Preferred Label : anti-inflammatory agents;

MeSH definition : Substances that reduce or suppress INFLAMMATION.;

MeSH synonym : anti inflammatories; antiinflammatory agents; agents, anti-inflammatory; agents, anti inflammatory; agents, antiinflammatory; antiinflammatories; anti-inflammatories; anti inflammatory agents; Antiinflammatory Agent; Agent, Antiinflammatory; Anti-Inflammatory Agent; Agent, Anti-Inflammatory; Anti Inflammatory Agent;

Wikipedia automatic translation : Anti-inflammatory;

MeSH annotation : do not confuse with INFLAMMATION MEDIATORS; DF: ANTI INFLAMM AGENTS or ANTIINFLAMM AGENTS; do not confuse with INFLAMMATION MEDIATORS;

Wikipedia link : https://en.wikipedia.org/wiki/Anti-inflammatory;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000893;

UMLS CUI

C0003209;

ATC code(s)
- antiinflammatory agents and antiinfectives in combination [ATC Code]
- naproxcinod [ATC Code]
ATC code(s)
- antiinflammatory agents [ATC Code]
- antiinflammatory agents [ATC Code]
- antiinflammatory agents and antiinfectives in combination [ATC Code]
- antiinflammatory and antirheumatic products [ATC Code]
- antiinflammatory products for vaginal administration [ATC Code]
- antiinflammatory/antirheumatic agents in combination [ATC Code]
- antiinflammatory/antirheumatic agents in combination with corticosteroids [ATC Code]
- fludrocortisone [ATC Code]
- intestinal antiinflammatory agents [ATC Code]
- other antiinflammatory therapeutic radiopharmaceuticals [ATC Code]
- other antiinflammatory/antirheumatic agents in combination with other drugs [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Anti-inflammatory [NCIt concept]
- antiinflammatory agents [ATC Code]
- antiinflammatory agents [ATC Code]
Indexing information
- 12-dehydrogingerdione [MeSH Supplementary Concept]
- 15,16-epoxy-3alpha-hydroxylabda-8,13(16),14-trien-7-one [MeSH Supplementary Concept]
- 2,4-bismethylthiobutanoic acid [MeSH Supplementary Concept]
- 2-deoxy-2-((o-methylbenzylidene))-beta-glucopyranoside [MeSH Supplementary Concept]
- 2-hydroxyobovaaldehyde [MeSH Supplementary Concept]
- 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole [MeSH Supplementary Concept]
- 3-acetyloxy-epicycloeucalenol-24-one [MeSH Supplementary Concept]
- 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile [MeSH Supplementary Concept]
- 5-(2-phenylethyl)-3-hydroxyphenol-1-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 5-(diphenylmethyl)-N-(3-chloro-4-fluorophenyl)-1,3,4-oxadiazol-2-amine [MeSH Supplementary Concept]
- 5-(diphenylmethyl)-N-(4-fluorophenyl)-1,3,4-oxadiazol-2-amine [MeSH Supplementary Concept]
- 6-(2-phenylethyl)-2,4-dihydroxy benzoic acid-2-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 6-methyl-2-(4-methylcyclohex-4-enyl-2-acetyloxy)hept-5-en-2-ol [MeSH Supplementary Concept]
- 6b,11b-dihydroxy-6b,11b-dihydro-7H-indeno(1,2-b)naphtho(2,1-d)furan-7-one [MeSH Supplementary Concept]
- 9-methoxyobovatol [MeSH Supplementary Concept]
- AM-461 [MeSH Supplementary Concept]
- CJ-20001 [MeSH Supplementary Concept]
- CTCE-0214 [MeSH Supplementary Concept]
- NOX-H94 [MeSH Supplementary Concept]
- Pamidronate [MeSH Descriptor]
- SEN1176 [MeSH Supplementary Concept]
- Tadenan [MeSH Supplementary Concept]
- Tropisetron [MeSH Descriptor]
- VBP15 compound [MeSH Supplementary Concept]
- alpha,beta-epoxy-carvone [MeSH Supplementary Concept]
- astrosterioside A [MeSH Supplementary Concept]
- astrosterioside D [MeSH Supplementary Concept]
- cheongseoikki-tang [MeSH Supplementary Concept]
- cistanoside K [MeSH Supplementary Concept]
- diterpenoid C, radix curcumae [MeSH Supplementary Concept]
- dopexamine [MeSH Supplementary Concept]
- effusanin C [MeSH Supplementary Concept]
- emu oil [MeSH Supplementary Concept]
- ent-3,4-seco-14-carbonyl-15,16-epoxy-4(18), 8(17),13(14)-labdatrien-3-oic acid [MeSH Supplementary Concept]
- erythraline [MeSH Supplementary Concept]
- euforia [MeSH Supplementary Concept]
- firategrast [MeSH Supplementary Concept]
- geleganimine B [MeSH Supplementary Concept]
- gitogenin 3-O-(O-glucopyranosyl-(1-2)-O-(O-rhamnopyranosyl-(1-4)-xylopyranosyl-(1-3))-O-glucopyranosyl-(1-4)-galactopyranoside) [MeSH Supplementary Concept]
- gitogenin 3-O-(O-glucopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-O-glucopyranosyl-(1-4)-galactopyranoside) [MeSH Supplementary Concept]
- glyceryl-isoeugenol [MeSH Supplementary Concept]
- hypericorin A [MeSH Supplementary Concept]
- hypericorin B [MeSH Supplementary Concept]
- jitongning [MeSH Supplementary Concept]
- magnobovatol [MeSH Supplementary Concept]
- methyl nicotinate [MeSH Supplementary Concept]
- methyl salicylate-2-O-beta-D-galactopyranoside (1-4)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- narivent [MeSH Supplementary Concept]
- osteochondrin S [MeSH Supplementary Concept]
- peironimev-plus [MeSH Supplementary Concept]
- penstyrylpyrone [MeSH Supplementary Concept]
- scolopendra alkaloids [MeSH Supplementary Concept]
- scorpio [MeSH Supplementary Concept]
- scutellarein tetramethyl ether [MeSH Supplementary Concept]
- shenshao [MeSH Supplementary Concept]
- syn-3,4-seco-12R-hydroxy-15,16-epoxy-4(18),8(17),13(16),14(15)-labdatetraen-3-oic acid [MeSH Supplementary Concept]
- teferidin [MeSH Supplementary Concept]
- tetranor-dihydrolipoic acid [MeSH Supplementary Concept]
- umbelliferone 6-carboxylic acid [MeSH Supplementary Concept]
Ne pas confondre avec
- inflammation mediators [MeSH Descriptor]
Record concept(s)
- Anti-Inflammatory agents [MeSH concept]
See also
- fever [MeSH Descriptor]
- inflammation [MeSH Descriptor]
See also (suggested by CISMeF)
- glucocorticoids [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1 alpha,24-dihydroxyvitamin D3 [MeSH Supplementary Concept]
- 2-(4-cyclohexyl-1-naphthalenyl)propanoic acid [MeSH Supplementary Concept]
- 4-chlorothiocolchicine [MeSH Supplementary Concept]
- 4-deoxypyridoxine [MeSH Supplementary Concept]
- 5-Methoxypsoralen [MeSH Descriptor]
- CXA-10 [MeSH Supplementary Concept]
- Compound 21 [MeSH Supplementary Concept]
- FX006 [MeSH Supplementary Concept]
- Fluticasone [MeSH Descriptor]
- LZ205 [MeSH Supplementary Concept]
- Lycopene [MeSH Descriptor]
- Methylprednisolone Acetate [MeSH Descriptor]
- Mometasone Furoate [MeSH Descriptor]
- Mulberrin [MeSH Supplementary Concept]
- Tobramycin, Dexamethasone Drug Combination [MeSH Descriptor]
- acetaminophen, pholcodine, pseudoephedrine drug combination [MeSH Supplementary Concept]
- alclometasone dipropionate [MeSH Supplementary Concept]
- algestone acetophenide [MeSH Descriptor]
- ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination [MeSH Supplementary Concept]
- avdoralimab [MeSH Supplementary Concept]
- beclomethasone [MeSH Descriptor]
- benzydamine [MeSH Descriptor]
- betamethasone [MeSH Descriptor]
- betamethasone acetate [MeSH Supplementary Concept]
- betamethasone benzoate [MeSH Supplementary Concept]
- betamethasone dipropionate, betamethasone sodium phosphate drug combination [MeSH Supplementary Concept]
- betamethasone valerate [MeSH Descriptor]
- betamethasone-17,21-dipropionate [MeSH Supplementary Concept]
- bindarit [MeSH Supplementary Concept]
- bisindolylmaleimide I [MeSH Supplementary Concept]
- budesonide [MeSH Descriptor]
- clobetasol [MeSH Descriptor]
- clobetasone butyrate [MeSH Supplementary Concept]
- clocortolone [MeSH Supplementary Concept]
- clofazimine [MeSH Descriptor]
- corticosterone [MeSH Descriptor]
- cortisone [MeSH Descriptor]
- cortivazol [MeSH Supplementary Concept]
- dapansutrile [MeSH Supplementary Concept]
- deflazacort [MeSH Supplementary Concept]
- desonide [MeSH Descriptor]
- desoximetasone [MeSH Descriptor]
- dexamethasone [MeSH Descriptor]
- dexamethasone acetate [MeSH Supplementary Concept]
- dexamethasone isonicotinate [MeSH Descriptor]
- diacerein [MeSH Supplementary Concept]
- diflorasone [MeSH Supplementary Concept]
- diflucortolone [MeSH Descriptor]
- diflucortolone valerate [MeSH Supplementary Concept]
- dimethyl sulfone [MeSH Supplementary Concept]
- emu oil [MeSH Supplementary Concept]
- fludrocortisone [MeSH Descriptor]
- flufenamic acid [MeSH Descriptor]
- flumethasone [MeSH Descriptor]
- flunisolide [MeSH Supplementary Concept]
- fluocinolone acetonide [MeSH Descriptor]
- fluocinonide [MeSH Descriptor]
- fluocortolone [MeSH Descriptor]
- fluorometholone [MeSH Descriptor]
- fluprednisolone [MeSH Descriptor]
- flurandrenolone [MeSH Descriptor]
- gadolinium chloride [MeSH Supplementary Concept]
- galiximab [MeSH Supplementary Concept]
- gimsilumab [MeSH Supplementary Concept]
- glycyrrhetinic acid [MeSH Descriptor]
- glycyrrhizic acid [MeSH Descriptor]
- halcinonide [MeSH Descriptor]
- halometasone [MeSH Supplementary Concept]
- heparinoids [MeSH Descriptor]
- hydrocortisone [MeSH Descriptor]
- hydrocortisone 17-butyrate 21-propionate [MeSH Supplementary Concept]
- hydrocortisone acetate [MeSH Supplementary Concept]
- hydrocortisone hemisuccinate [MeSH Supplementary Concept]
- hydrocortisone, urea drug combination [MeSH Supplementary Concept]
- indomethacin farnesil [MeSH Supplementary Concept]
- lenzilumab [MeSH Supplementary Concept]
- lorecivivint [MeSH Supplementary Concept]
- lupeol [MeSH Supplementary Concept]
- methylprednisolone [MeSH Descriptor]
- methylprednisolone aceponate [MeSH Supplementary Concept]
- methylprednisolone hemisuccinate [MeSH Descriptor]
- nangibotide [MeSH Supplementary Concept]
- paramethasone [MeSH Descriptor]
- plonmarlimab [MeSH Supplementary Concept]
- prednicarbate [MeSH Supplementary Concept]
- prednisolone [MeSH Descriptor]
- prednisolone acetate [MeSH Supplementary Concept]
- prednisone [MeSH Descriptor]
- remestemcel-l [MeSH Supplementary Concept]
- rilonacept [MeSH Supplementary Concept]
- sambulin [MeSH Supplementary Concept]
- schizandrin B [MeSH Supplementary Concept]
- tebufelone [MeSH Supplementary Concept]
- tilorone [MeSH Descriptor]
- triamcinolone [MeSH Descriptor]
- triamcinolone acetonide [MeSH Descriptor]
- triamcinolone hexacetonide [MeSH Supplementary Concept]
- umirolimus [MeSH Supplementary Concept]
- xhance [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-inflammatory agent (substance) [Inactive SNOMED CT concept]
- Anti-inflammatory drug [ICD-11 Extension code]
- Medicinal product acting as antiinflammatory agent (product) [SNOMED CT concept]
- anti-inflammatory agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients